Linda M. Rubinstein, Chief Financial Officer at Adverum Biotechnologies, Inc. (ADVM), bought 100,000 shares at $1.45 ($145K) on 2023-06-07, disclosed to the SEC on 2023-06-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |